This round-up features Daiken Biomedical’s Japanese patent, positive effects of probiotic strain Bifidobacterium breve M-16V, Meiji and Albion’s collaborative launch, Asahi-funded study on yeast mannan, and CBD brand CURE’s Japan debut plans.
The supplementation of the probiotic strain Bifidobacterium breve M-16V has shown to modulate the nervous system, such as decreasing heart rate during stress and increasing the production of pipecolic acid – a GABA-like substance for supporting stress relief, according to a six-week study.
The supplementation of the probiotic strain Bifidobacterium breve M-16V has shown to modulate the nervous system, such as decreasing heart rate during stress and increasing the production of pipecolic acid – a GABA-like substance for supporting stress relief, according to a six-week study.
Printing News is now part of WhatTheyThink. PrintingNews.com has been archived to preserve all the news, magazine features and other content published on the site.